论文部分内容阅读
本文论逆了“一药多名”问题的现状,探究了“一药多名”问题产生的根源,以及与药品名称相关的药事法律法规及其发展历程,提出了解决这一问题的方案.
This article discusses the current situation of the problem of “one drug more than one” and explores the root causes of the problem of “one drug more than one” and the laws and regulations of pharmaceuticals related to the name of the drug and its development history. A solution to the problem.